← All trials
NCT05893472
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2023
- Primary completion
- Apr 1, 2024
- Completion date
- Apr 1, 2024
- First posted
- Jun 8, 2023
- Last posted
- Jun 8, 2023
- Enrollment
- 45
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kunming Medical UniversityLead sponsor
- Guizhou Medical UniversityCollaborator
- Handan Central HospitalCollaborator
- Central South UniversityCollaborator
- Tai'an Central HospitalCollaborator
- Kunming Medical UniversitySponsor investigator
- Tianjin Medical UniversityCollaborator
- Kunming Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.